Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia

doi:10.4251/wjgo.v14.i3.724

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4495)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

245

WORD

108

HTML

1613

Figures (1-3)

279

Tables (1-3)

329

Sum=2574

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

314

Download

625

Sum=939

Publishing Process of This Article

Item

Count

Browse

251

Download

731

Sum=982

Mar 15, 2022 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Mar 15, 2022; 14(3): 724-733
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.724

Full Size Figure Download Figure

Figure 3 Relapse-free survival curves. A: Non-Helicobacter pylori (H. pylori) infection vs H. pylori infection (P < 0.001); B: Disease course less than 1 year vs disease course over 1 year (P = 0.013). RFS: Relapse-free survival.

Citation: Wang NJ, Chai NL, Tang XW, Li LS, Zhang WG, Linghu EQ. Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia. World J Gastrointest Oncol 2022; 14(3): 724-733
URL: https://www.wjgnet.com/1948-5204/full/v14/i3/724.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.724